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Currently, porcine circovirus type 2 (PCV2) is considered the major pathogen of porcine circovirus associated-diseases
(PCVAD) that causes large economic losses for the swine industry in the world annually, including China. Since the
first report of PCV2 in 1998, it has been drawing tremendous attention for the government, farming enterprises,
farmers, and veterinary practitioners. Chinese researchers have conducted a number of molecular epidemiological
work on PCV2 by molecular approaches in the past several years, which has resulted in the identification of novel
PCV2 genotypes and PCV2-like agents as well as the description of new prevalence patterns. Since late 2009,
commercial PCV2 vaccines, including the subunit vaccines and inactivated vaccines, have already been used in
Chinese swine farms. The aim of this review is to update the insights into the prevalence and control of PCV2 in
China, which would contribute to understanding the epidemiology, control measures and design of novel vaccines
for PCV2.
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Porcine circoviruses (PCVs), the smallest known animal
viruses, including PCV1 and PCV2, are members of the
genus Circovirus in the Circoviridae family. PCV1 was
first discovered in 1974 as a contaminant of the porcine
kidney cell line PK-15 (ATCC CCL-33) and was consid-
ered non-pathogenic [1,2]; Whereas PCV2 was isolated
from pigs suffering from post-weaning multisystemic
wasting syndrome (PMWS) over 20 years later [3].
Generally, PCV1 genome consists of 1759 nucleotides
(NTs), while PCV2 has 1767 or 1768 NTs. PCV1 has
only one genome map (Figure 1). For PCV2, it has three
kinds of genome organisation, map 1, map 2 and map 3,
respectively (Figure 1). PCV2 has three major open read-
ing frames (ORFs), ORF1 (945 NTs, position 51 to 995),
ORF2 (702 or 705 NTs, position 1734/1735 to 1030/
1033/1034) and ORF3 (315 NTs, position 671 to 357),
respectively (Figure 1). The three ORFs encode replicase* Correspondence: luoml@scau.edu.cn; wwk188@tom.com
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unless otherwise stated.protein that involves in viral replication (to attain self-
replication), the immunogenic capsid protein and the
viral pathogenesis-associated protein, respectively [4-6].
One latest study reported that a newly discovered viral
protein, ORF4 (180 NTs, position 386 to 565), was not
essential for PCV2 replication yet having a role in sup-
pressing caspase activity and regulating CD4(+) and
CD8(+) T lymphocytes during PCV2 infection [7].
For life cycle of PCV, firstly, PCV uses glycosaminogly-
cans (GAG) as attachment receptors. The ssDNA gen-
ome is transported into the nucleus and converted by
host enzymes into a dsDNA intermediate. The rep and
cap mRNAs are transcribed to synthesize proteins,
which are then imported from the cytoplasm. Rep/Rep’
then binds to the dsDNA and initiates rolling-circle rep-
lication (RCR) by introduction of a nick, which serves as
primer [8]. Elongation of the primer by host enzymes
leads to replication (Figure 2). Meanwhile, the Rep pro-
tein is covalently bound to the DNA and terminates the
reaction by introduction of a second cleavage reaction
via Tyr-93 (Figure 2). How viruses were assembled and
released, have not yet been studied [8].
PCVs, especially PCV2, cause huge hazards to swine in-
dustry. At present, PCV2 is associated with a number of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Genome maps of PCV1 and PCV2. Note: Generally, maps of PCV2a & PCV2e, PCV2b, PCV2d & PCV2c, are corresponding to Map 1
(PCV2), Map 2 (PCV2) and Map 3 (PCV2), respectively.
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http://www.virologyj.com/content/11/1/88diseases, collectively known as porcine circovirus diseases
(PCVD) in Europe [9], or porcine circovirus-associated
diseases (PCVAD) in North America [10]. Apart from
PMWS, PCVD/PCVAD also includes reproductive disor-
ders [11], porcine dermatitis and nephropathy syndrome
(PDNS) [12], nervous system lesions [13], porcine respira-
tory disease complex (PRDC) [14], enteritis [15,16], and
proliferative and necrotizing pneumonia (PNP) [17,18].
Recently, a new PCV2-related disease syndrome called
acute pulmonary edema (APE) that is different from thePCVD/PCVAD syndromes mentioned above was de-
scribed in U.S. swine herds vaccinated with PCV2 [19].
A number of field and experimental studies that were
performed in some countries of North America, Europe
and Asia indicated that commercial vaccines (based on
genotype PCV2a) against PCV2 were effective in many
aspects, including reducing the incidence of PMWS, the
number of co-infections, the severity of lesions in
lymphoid tissues [20-25], the level of PCV2 viraemia and
the severity of microscopically-visible lesions [26-29] as
Figure 2 Life cycles of PCV. Note: The figure was showed in the previous reference [8]. Abbreviations: Glycosaminoglycans (GAG); Rolling-circle
replication (RCR); Minimal binding site (MBS).
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version ratios [20-25]. However, due to the subsequent
possible vaccination pressure, novel variant strains or ge-
notypes (such as PCV1/2, PCV2d) emerged in Canadian
and U.S. swine herds [30-32].
In recent years, due to continuous losses caused by
PCVD, the government at home and abroad supports sci-
entists’ great deal of work on molecular epidemiology
and vaccine development of PCV2. The aim of the review
is to update the insights on the prevalence and control of
PCV2 in China, which would help in understanding of
the epidemiology, adjusting control measures, and the
design of novel vaccines against PCV2.
Review
PCV2 Genotypes in China
After the first identification of PCV2 in China in 1998, a com-
prehensive molecular epidemiological survey was performed
in different regions of China between 2001 and 2003 [33].
The results based on full-length ORF2 sequence level identi-
fied nine different genotypes (CHN-2A, CHN-2B, CHN-2C,
CHN-2D, CHN-2E, CHN-2F, CHN-2G, CHN-2H, and
CHN-2I) using restriction fragment length polymorphism
(RFLP) analysis. Additional PCV2 genotypes were also re-
ported [34-40]. Subsequently, in order to counteract the
current scientific confusion on genotype nomenclature, the
EU consortium on PCVD (www.pcvd.net/) proposed a uni-
fied nomenclature (ORF2 sequences of PCV2 are assigned
into different genotypes when the genetic distance among
them is at least 0.035) for the PCV2 genotype. The consor-
tium proposed naming the three PCV2 genotypes as PCV-
2a, PCV-2b, and PCV-2c [41]. On the other hand, accord-
ing to the nomenclature of Wang and co-workers [42],
Chinese PCV2 strains based on complete genome were
classified into PCV2a, PCV2b, PCV2d, PCV2e (Figure 3),
and other unidentified genotypes [42-45]. Nevertheless,
Segalés et al. [46] had different comments towards the
above nomenclatures and argued that PCV2 should still bedivided into only three genotypes. In general, these PCV2
strains had three kinds of genome maps and two kinds of
genome sizes (Figure 1) [45]. A few studies reported a num-
ber of PCV2 variant strains in China [47-50] but the
method proposed by EU consortium on PCVD was not uti-
lized. The PCV2c genotype has not been reported so far. In
summary, regardless of the classification methods, the
above studies demonstrated that various PCV2 genotypes
did exist in swine herds of China.
Co-Infections of Different PCV2 Genotypes in the Field
in China
In 2009, Hesse et al. [51] described natural co-infections of
two different PCV2 genotypes in pigs in the field for the first
time. A similar molecular epidemiological survey using 118
PCV2-positive samples between 2008 and 2009 was also
conducted by our group. Our result indicated that the co-
infection rates of PCV2 were 32.2% (38/118) in diseased pigs
and 0% (0/41) in asymptomatic pigs, respectively. Sequen-
cing results of the 38 co-infected samples showed that the
co-existent genotypes were PCV2a-PCV2b (12/38), PCV2a-
PCV2d (15/38), and PCV2e-PCV2d (11/38), respectively.
This was the first study demonstrating the co-existence of
different PCV2 genotypes or strains in China that could help
better understand the molecular epidemiology and the new
infection patterns of PCV2 [52]. We believe that the pres-
ence of co-infections of different PCV2 genotypes is a more
accurate description with regard to the molecular epidemi-
ology, supported by common observations in the field.
Co-Infections of PCV2 with Other Swine Pathogens
in China
In addition to co-infections of different PCV2 genotypes,
a number of studies demonstrated that PCV2 could co-
infect along with by other traditional pathogens (such as
porcine reproductive and respiratory syndrome virus,
classical swine fever virus, porcine parvovirus, porcine
pseudorabies virus, bovine viral diarrhea virus) [53-59]
Figure 3 Phylogenetic analysis of diversified PCV strains. Note: The phylogenetic tree was constructed using the neighbor-joining method with
MEGA 5.1 software. The reliability of the different phylogenetic groupings was evaluated by using the bootstrap test (1000 bootstrap replications).
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teno sus virus, porcine hokovirus) [60-63].
Novel PCV2 strains in China
PCV2 Strains with nucleotide deletion
In general, the full-length genome of PCV2 is 1767 bp
or 1768 bp in size. However, PCV2 strains with gene dele-
tion were identified in China. TZ0601 strain (GenBankaccession number EU257511) had one nucleotide (G) dele-
tion in the ORF2 region (Position 1733 to 1026) at position
1059 (Figure 4), resulting in C-terminal truncation of ORF2
[64]. Similarly, YJ strain (HM038032) also had one nucleo-
tide (G) deletion in the ORF2 region (Position 1733 to
1026) (Figure 4), but the deletion occurred at position 1039
[43]. Due to one nucleotide (G) deletion in ORF2 encoding
region, for the strains of TZ0601 and YJ, the size of ORF2
Figure 4 Genome maps of four deletion strains and two insertion strains of PCV2. For TZ0601 and YJ, the nucleotide (G) deletion occurred
at position 1059 and 1039, respectively. AH and MDJ had an identical nucleotide (G) deletion at position 39. Moreover, for two insertion strains,
10JS-2 had 11-nt (AGCAGCACCTC) insertion at position 42, while JF2 had one nucleotide (T) insertion at position 1043.
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http://www.virologyj.com/content/11/1/88is lengthened from 702 bp to 708 bp. In addition, the AH
strain (HM038030) and MDJ strain (HM038031) had an
identical deletion (C) in the non-coding region at position
39 [43], it suggested that position 39 was a frequent dele-
tion site, despite the fact that these deletions did not affect
the ORF1 and ORF2 encoding proteins (Figure 4).Figure 5 Genome maps of four PCV2 recombinant strains. HN0907 wa
(Position 51 to 413) were from ZhuJi2003 (AY579893, PCV2b) and nucleotid
09HaiN-1 was an inter-genotypic recombinant between PCV2a and PCV2b
the breakpoint 309 of ORF2, and shared higher sequence similarity with GS
SXXYA-01 was an inter-genotypic recombinant between PCV2a and PCV2b
(AY579893) and the remaining sequences were most from DTC (DQ104423
PCV2b strains, its sequence exhibited higher similarity to DTC (DQ104423, P
(AY579893, PCV2b) after the breakpoint 1034 nt. Note: The recombinant rePCV2 Strains with nucleotide insertion
In 2004, a novel PCV2 strain, named Fh16 (AY321993),
with gene insertion (11 nt, GGCAGCACCTC) at pos-
ition 42 (non-coding region from position 1 to 50) was
identified in non-PMWS herds in France. However,
those herds presented with wasting, necrosis, ands an intra-genotypic recombinant between PCV2b strains, nucleotides
es (Position 414 to 995) were from 09CQ (HQ395024, PCV2b).
strains, it exhibited greater similarity to 336 (AY256459, PCV2a) before
LN-PCV2 (FJ948168, PCV2b) after the breakpoint 309 of ORF2.
strains, nucleotides (Position 1034 to 1391) were most from ZhuJi2003
). SXXYB-01 was an inter-genotypic recombinant between PCV2a and
CV2a) before the breakpoint 1034 nt and higher similarity to ZhuJi2003
gions were presented using red squares and blue squares.
Figure 6 (See legend on next page.)
Zhai et al. Virology Journal 2014, 11:88 Page 7 of 13
http://www.virologyj.com/content/11/1/88
(See figure on previous page.)
Figure 6 Genome maps of eight PCV2-like agents. For P1, twenty-two nucleotides (GGATCCACTAGTAACGGCCGCC) from 5'-terminal region
might originate from porcine endogenous retroviruses and the rest of the sequence shared 98.42% identity with ORF2 of PCV2 genome
(AF381175). For P2, its ORF3 sequences shared 64.7% ~ 97.4% identity with ORF2 of PCV genome. For JSTZ, ZJQDH1 and ZJQDH2, online Blastn
results showed they shared hightest nucleotide identity (98% ~ 100%) with the partial sequences of PCV2 (the strain of GZ-CS1, JQ809462). For
JSHM, online Blastn results showed it shared hightest nucleotide identity (98% ~ 100%) with the partial sequences of PCV2 (the strain of CQWZ12,
KF742551). For CH-IVT1, online Blastn results showed it shared hightest nucleotide identity (100%) with the partial sequences of PCV2 (the strain
of BF, AF381175). For BIV, online Blastn results showed it shared hightest nucleotide identity (99%) with the partial sequences of PCV2 (the strain
of 10JS-2, JQ806749). Note: Complete genomes of P1 and P2 were showed in reference [78] and reference [76], respectively.
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multocida. Further genetic analysis showed that Fh16
was belonged to the genotype PCV2b [35]. Furthermore, a
Danish PCV2 strain DK475case (EF565360) isolated from
non-PMWS herds had the identical 11-nt nucleotide
insertion to the Fh16 strain [65].
PCV2 strains with nucleotide insertion also exist
in China. Among them, the 10JS-2 strain (JQ806749)
had 11-nt insertion (AGCAGCACCTC) at position 42
(Figure 4), which was similar to the strains Fh16 and
DK475case [66]. The strain JF2 (HQ402903) had one
additional nucleotide insertion (T) at position 1043 com-
paring to the genotype PCV2a, which led to the changes
of ORF2 size (711 bp) (Figure 4) comparing to the previ-
ous strains [67]. Notably, phylogenetic analysis suggested
that the strains 10JS-2 and JF2 were classified into the
genotype of PCV2e and PCV2a, respectively (Figure 3).PCV2 Recombinant strains
Recombination is an important evolution pathway for vi-
ruses. PCV2 is a virus with rapid evolution. Recombination
events of PCV2 have been reported from several countries
including China since 2007 [30,39,51,68-75]. These recom-
binant strains did not only arise from intra-genotypic re-
combination but also inter-genotypic recombination
(Figure 5). However, some recombinants’ origins might beFigure 7 Possible infection and cross-species transmission routes of Pdoubtful due to artificial genome amplification and/or lack
of viral plaque purification tests.
PCV2-Like viral agents
Porcine circovirus-like agents (P1 and P2) were found in
China in 2008. Sequence analyses indicated that the two
new agents had 648 nucleotides (P1) and 993 nucleo-
tides (P2) in size (Figure 6), which were closely related
to the isolates of PCV2 [76-78]. Epidemiology studies
and animal experiments also demonstrated that P1,
which caused pallor of the skin and diarrhea in pigs, had
a high prevalence in Chinese swine herds [77,79]. Since
then, more porcine circovirus-like strains (Figure 6) were
reported [80-82]. However, these PCV2-like strains were
reported only by one research team. More epidemio-
logical work should thus be done in order to confirm
their actual existence and pathogenicity.
PCV2 DNA in Chinese commercial swine vaccines
PCV1 is non-pathogenic to pigs, and it is often detected
in cell lines, pepsin, and commercial swine vaccines
[83-87]. However, some studies reported that PCV2
DNA also existed in human stool, human vaccines, beef,
calf bone marrow, rodents, and even commercial swine
vaccines in China [88-93]. Infections of pigs and PCV-
associated diseases by vaccination (Figure 7) would haveCV in pigs.
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http://www.virologyj.com/content/11/1/88occurred if PCV2 retained its infectivity in those com-
mercial swine vaccines. To some extent, it has warned
the vaccine manufacturers that good quality control
measures should be taken in order to avoid the spread
of PCV2 through contaminated vaccines, especially live
vaccines.
PCV2 DNA in mosquitoes collected from China
PCV2 has a high prevalence in swine herds in the world,
implying that there might be other transmission routes
(Figure 7). Recently, extensive PCV2 DNA was detected
from water samples in Brazil, farm air in Canada, house
flies in UK, and even in Culex (a kind of mosquito)
(6.78%, 4/59 sampling) collected in China [94-97]. In
general, mosquito is considered as an important vector
for many zoonotic infectious diseases, such as Japanese
encephalitis B and dengue fever. The control and killing
of this vector (such as Culex and house flies) is usually
overlooked under the poor swine farm conditions in
China, which might exacerbate the spread of PCV2 in
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Vaccine
Safe and effective vaccines are considered as the best
control measure for viral diseases. Commercial PCV2
vaccines (including the subunit vaccine, inactivated
PCV1-2 chimera vaccine and inactivated PCV2 vaccine)
have been proven to be effective in the EU, North America,
and South Korea [98]. In recent years, PCV2 is given more
attention by farming enterprises and the government in
China. Since the first imported vaccine (Ingelvac circoflex,
Boehringer Ingelheim, Ltd.) being available in China at the
end of 2009, there have been at least five commercial vac-
cines (one subunit vaccine and four inactivated vaccines)
from 16 manufacturers (Table 1). Among these vaccines,
one vaccine is based on PCV2d genotype, two vaccines
are based on PCV2a genotype and three vaccines are
based on PCV2b genotype. In general, PCV2 vaccines in-
duced a humoral immune response, characterized by pro-
ducing neutralizing antibodies (NA) that are cross-
protective against both predominant PCV2 genotypes in
conventional pigs [26]. Besides, the infection tests basedGenBank
accession No.
Administration Licensed for
Not available 1 mL IM
single dose
Piglets (>2 weeks of age)
AY686763 1 mL IM
single dose
Piglets (14–21 days);
2 mL IM 2 doses Gilts (45 days before mating/3
weeks later; Prenatal 30–40 days);
Productive sows (Prenatal about
45 days/3 weeks later)
HM038034 1 mL IM
single dose
Piglets (3–4 weeks);
2 mL IM 2 doses Gilts (before mating/3 weeks later;
Prenatal 30 days); Productive sows
(Pregnancy/ Prenatal 30 days);
Normal vaccination for others
HM641752 1 mL IM
single dose
Piglets (14–21 days/14 days later)
FJ598044 2 mL IM
single dose
Piglets (21–28 days)
Not available 2 mL IM
single dose
Piglets (>14 days)
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strated that cross-protection was present between PCV2a
and PCV2b [99,100]. However, one recent study re-
ported that a PCV2 vaccine based on genotype PCV2b
was more effective in protecting pigs against the effects
of PCV2b than those based on the genotype PCV2a
[101]. The result could act as a further support for the
antigenic variability of PCV2 [64,102]. Moreover, se-
quence varieties between PCV2 isolates could translate
to functional antigenic differences in viral neutralization
in vivo [103].
Other measures
In addition to vaccination, other comprehensive mea-
sures have been taken in China, which mainly followed
the recommendations in the developed countries, such as
“Madec’s 20-point plan”, including “all-in”–“all-out” pro-
cedures, disinfection, limiting animal contact, preventing
mixing of batches and cross-fostering and the isolation
or euthanasia of diseased pigs; It also included the envi-
ronmental factors such as the maintenance of appro-
priate temperature, air-flow, and space within pens; and
furthermore, appropriate use of anti-parasitic treatments
and vaccination [104], co-infections control [105-107],
breeding and semen quality control [108-110], and herd
nutrition improvement [111-113] are included as well.
Nevertheless, autogenous vaccines were also considered
as an effective method to prevent and control PCV2 on
some pig farms from our experience.
Conclusions
In summary, PCV2 infection is very common in Chinese
swine herds. There are various PCV2 genotypes, PCV2-
like strains, or mutants circulating in China. Together
with the potential cross-species transmission of PCV2
(Figure 7), these factors lead to great challenges for the
control of PCV2 despite the availability of vaccines.
Furthermore, although cross-protection within inter-
genotypes of PCV2 is present, NA only neutralizes cer-
tain PCV2 genotype but not all PCV2 genotypes [103].
At present, PCV2 infection status can be quite complex
clinically, if it is not mastered well by veterinarians or
practitioners. It might hinder choosing the right choice
of PCV2 vaccines and thus not conducive to the preven-
tion of PCV2. To overcome this problem, it is necessary
to perform the detection and sequencing of PCV2 anti-
gen. In addition to effective comprehensive measures, the
development of polyvalent vaccines (such as PCV2a +
PCV2b + PCV2d) or universal vaccines against all PCV2
genotypes are needed in the future.
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